Posted inBiotechnology
Connect’s Dupixent rival reduces COPD attacks by 85%, but misses a secondary goal
Connect Biopharma has pointed to phase 2 data for its IL-4/IL-13 blocker as proof that the wannabe Dupixent rival can…
Posted inMedical Technology
VertigoDx on firm ground with FDA greenlight for vertigo diagnostic system
The FDA has granted 510(k) clearance to Miami-based VertigoDx for its portable diagnostic system that can evaluate vertigo, including benign…
Posted inBiotechnology
Roche, Zealand see phase 2 amylin weight loss peak at mid-dose, start pivotal program
Zealand Pharma has shared primary endpoint data on Roche-partnered petrelintide, revealing that the middle dose of the amylin analog delivered the…
Posted inBiotechnology
Amgen reveals 6-point drop in lupus severity behind phase 2 win for Horizon antibody
Amgen has shed light on its phase 2 lupus win, revealing that its monoclonal antibody daxdilimab was tied to a…
Posted inBiotechnology
Lilly sets up next-gen obesity battle with full phase 3 retatrutide data
Eli Lilly has shared detailed data from a phase 3 retatrutide trial, revealing that more than one-third of patients on the…
Posted inGenetics
AI and Proteomics Accelerate VAV1 Molecular Glue Discovery
Molecular glues act as matchmakers with a destructive streak: They bring disease-linked proteins into contact with the cell’s disposal machinery,…
Posted inGenetics
Merck, SciBrunch Launch Up-to-$2.13B Collaboration to Develop Preclinical KRAS-Inhibiting Molecular Glue
Merck & Co. has acquired exclusive global rights to develop, manufacture, and commercialize SciBrunch Therapeutics’ preclinical oral precision cancer candidate…
Posted inGenetics
Ginkgo Datapoints, Apheris Announce Founding Members of Antibody Developability Consortium
Ginkgo Datapoints and Apheris have announced the founding members of the Antibody Developability Consortium, a new industry collaboration designed to…
Posted inGenetics
How Cells Respond Differently to a Cancer-Causing Gene
Scientists at NYU Abu Dhabi say they have discovered that a single cancer-causing gene can trigger different responses in cells,…
Posted inGenetics
Current Challenges in CAR T Manufacturing
CAR T therapy has undergone a remarkable transformation over the past decade, evolving from an experimental treatment into a clinically…